Financial Summary -
Novo Consulting & Clinical Research Services Srl
Unique identification code:34055353
Registration number:J40/1236/2015
Nace:4619
Sales - Ron
51.043
Net Profit - Ron
14.550
Employees
1
Open Account
Company Novo Consulting & Clinical Research Services Srl with Fiscal Code 34055353
recorded a turnover of 2024 of
51.043,
with a net profit of
14.550
and having an average number of employees of
1.
The company operates in the field of Intermedieri în comerţul cu produse diverse having the NACE code 4619.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Novo Consulting & Clinical Research Services Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
23.147
28.263
26.093
24.491
24.306
25.582
25.096
40.199
53.298
51.043
Total Income - EUR
23.147
28.263
26.093
24.491
24.306
25.582
25.096
40.199
53.298
51.194
Total Expenses - EUR
14.072
14.475
9.399
14.889
17.520
17.440
29.271
23.960
24.116
36.142
Gross Profit/Loss - EUR
9.076
13.789
16.694
9.602
6.786
8.142
-4.175
16.240
29.182
15.052
Net Profit/Loss - EUR
8.381
12.941
16.047
9.357
6.543
7.898
-4.421
15.846
28.660
14.550
Employees
0
0
1
1
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -3.7%, from 53.298 euro in the year 2023, to 51.043 euro in 2024.
The Net Profit decreased by -13.950 euro, from 28.660 euro in 2023, to 14.550 in the last year.
Check the financial reports for the company - Novo Consulting & Clinical Research Services Srl
Financial Rating - NOVO CONSULTING & CLINICAL RESEARCH...
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Novo Consulting & Clinical Research...
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Novo Consulting & Clinical Research...
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Novo Consulting & Clinical Research...
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Novo Consulting & Clinical Research Services Srl - CUI 34055353
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
0
0
0
0
0
0
0
0
0
782
Current Assets
9.121
13.205
29.270
38.056
43.963
51.247
45.541
50.437
56.270
70.740
Inventories
0
0
0
0
0
0
38
39
0
0
Receivables
981
13.100
27.534
36.768
43.200
50.079
45.140
49.596
54.531
70.631
Cash
8.140
104
1.736
1.288
763
1.167
362
803
1.739
109
Shareholders Funds
8.426
12.985
28.812
37.641
43.455
50.529
44.988
48.550
55.748
69.987
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
694
219
458
415
508
718
553
1.887
523
1.535
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4619 - 4619"
CAEN Financial Year
4619
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
70.740 euro in 2024 which includes Inventories of
0 euro, Receivables of
70.631 euro and cash availability of
109 euro.
The company's Equity was valued at
69.987 euro, while total Liabilities amounted to
1.535 euro.
Equity increased by 14.550 euro, from 55.748 euro in 2023, to 69.987 in 2024.
Reviews - Novo Consulting & Clinical Research Services Srl
Comments - Novo Consulting & Clinical Research Services Srl
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Novo Consulting & Clinical Research Services Srl